ArticleScientific reports2025
The neutrophil-to-lymphocyte ratio is associated with increased risk of all-cause mortality in obstructive sleep apnea.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Beyond the Apnea-Hypopnea Index: Circulating Biomarkers and Device-Based Metrics for Cardiometabolic Risk Stratification in Obstructive Sleep Apnea.Journal of clinical medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
The association between neutrophil-to-lymphocyte ratio (NLR), an inflammatory marker, and all-cause mortality among individuals with obstructive sleep apnea (OSA) remains unclear. This study aimed to evaluate the association of NLR with all-cause mortality among individuals with OSA. A total of 4,085 participants with OSA were selected from the National Health and Nutrition Examination Survey (NHANES) conducted between 2005 and 2008, with follow-up data collected until December 31, 2019. Weighted Cox regression analyses were used to explore the association between the NLR and all-cause mortality. Nonlinear associations were detected using restricted cubic splines (RCS). Subgroup analyses were further performed to explore these relationships. The mean follow-up time for the entire cohort was 137.7 months. There was a clear trend of increasing mortality risk with higher NLR quartiles, rising from 11.86% in Q1, 13.41% in Q2, 14.81% in Q3, to 29.22% in Q4. The Cox regression analysis revealed that lnNLR was associated with an increased risk of all-cause mortality after full adjustment (hazard ratio [HR] = 1.81, 95% CI 1.43-2.30, p < 0.001). RCS showed a J-shaped relationship between lnNLR with all-cause mortality (p-non-linear < 0.001). The interaction tests found that coronary heart disease (CHD) influenced the association between lnNLR and all-cause mortality, with a HR of 3.98 for those with CHD and 1.62 for those without CHD (p = 0.008). There was a nonlinear correlation between elevated NLR and increased risk of all-cause mortality among OSA individuals. The association was more pronounced among CHD subgroups. Future research should explore the underlying mechanisms and evaluate whether therapies targeting inflammation can lower mortality risk in OSA patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.